- Conditions
- Chronic Lymphoproliferative Diseases (CLPD)
- Interventions
- IUO CLPD Limited Panel
- Diagnostic Test
- Lead sponsor
- Becton, Dickinson and Company
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 371 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 2
- States / cities
- Chapel Hill, North Carolina • San Antonio, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–2
of 2
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Chronic Lymphoproliferative Diseases (CLPD)
- Interventions
- BD OneFlow LST, and B-CLPD T1 to T4 Assays
- Diagnostic Test
- Lead sponsor
- Becton, Dickinson and Company
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 322 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 2
- States / cities
- Chapel Hill, North Carolina • San Antonio, Texas